Outcomes of long-term anticoagulant treatment for the secondary prophylaxis of splanchnic venous thrombosis.
Alessandra SerraoManuela MerliBenedetta LucaniFrancesca AprileLuciano FioriStefania GioiaMassimo BrecciaOlivero RiggioAntonio ChistoliniPublished in: European journal of clinical investigation (2020)
Our results highlight that DOACs could represent an effective and safe alternative to the VKA for secondary prophylaxis in SVT patients at high risk of thrombosis.